Dental Care Clinics in Flushing, MI Accepting Medicare
10 Dental Care Clinics found. Showing 1 - 10
 James K. Cantwil Dds, Plc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6210 W Pierson Rd, Flushing, MI 48433 Phone: 810-733-6677 |
Mark Anderson, Dds, Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 6011 W Pierson Rd, Flushing, MI 48433 Phone: 810-733-5566 |
Jeffrey T Straley Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 113 S Cherry St, Flushing, MI 48433 Phone: 810-659-5512 |
Eric Romano Dds Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 3444 Pierson Pl, Flushing, MI 48433 Phone: 586-733-2750 |
Bt Dental Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 113 E Main St, Flushing, MI 48433 Phone: 810-659-4561 Fax: 810-213-0216 |
Flushing Family Dental Care Pllc Dentist Medicare: Not Enrolled in Medicare Practice Location: 323 W Main St, Flushing, MI 48433 Phone: 810-659-7800 Fax: 810-659-8706 |
Shukairy Dentistry Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 323 W Main St, Flushing, MI 48433 Phone: 810-659-7800 Fax: 810-659-8706 |
Richard Dean Ebert Dds Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1319 E Main St, Flushing, MI 48433 Phone: 810-659-9131 |
Flushing Dental Care Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 6221 W Pierson Rd, Flushing, MI 48433 Phone: 810-733-2700 |
Natalya A Brezden Dds Pllc Dentist Medicare: Not Enrolled in Medicare Practice Location: G-6221 W Pierson Rd, Flushing, MI 48433 Phone: 810-733-2700 Fax: 810-733-3638 |
News Archive
Agios begins AG-348 Phase 1 study to treat PK deficiency
Agios Pharmaceuticals, Inc., a leader in the fields of cancer metabolism and inborn errors of metabolism (IEM), today announced dose administration of AG-348 in a Phase 1 study in healthy volunteers.
FDA grants Breakthrough Therapy designation to Boehringer Ingelheim's nintedanib
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation to nintedanib, an investigational therapy currently under FDA review for the treatment of people with idiopathic pulmonary fibrosis (IPF).
Experimental therapy uses immune system to boost cure rate in neuroblastoma
A multicenter research team has announced encouraging results for an experimental therapy using elements of the body's immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system.
Beckman Coulter receives BARDA funding to develop novel sepsis detection algorithm
Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised, from the DRIVe (Division of Research, Innovation, and Ventures) established by the Biomedical Advanced Research and Development Authority, under the Office of the Assistant Secretary for Preparedness and Response, within the United States Department of Health and Human Services.
Axis Three launches 3D surgical simulation platform at Plastic Surgery 2009
At Plastic Surgery 2009, Axis Three (www.axisthree.com), the leader and pioneer of 3D surgical simulation tools for the cosmetic surgery industry, today introduced its Portrait 3D Face Simulation Module, the Company's latest innovation in its 3D surgical simulation technology.
› Verified 6 days ago